
Trump Threatens 100% Tariffs on Patented Drugs Unless Firms Build U.S. Plants
Published September 26, 2025
Share this card
A satirical card depicting the dramatic ultimatum: 100% tariffs on branded drug imports unless pharmaceutical firms break ground on U.S. factories, showing collapsing foreign drugmakers and frantic domestic build efforts.
Trump announced that starting October 1, the U.S. will impose a 100% tariff on imported branded or patented pharmaceutical products, unless the companies are actively building manufacturing plants in the U.S. The exemption applies only to firms that are already “breaking ground” or “under construction.” Generic drugs aren’t included in the measure. The move is intended to force onshoring of drug production and reduce reliance on foreign pharmaceutical imports.
Read the original article →U.S. Military's Epic Iran Blunder Becomes Spectacular Failure
Mar 19, 2026
Fed Holds Interest Rates Amid Uncertainty Over Iran Conflict
Mar 18, 2026
Israel's Latest Target: Iran Intelligence Minister Assassinated
Mar 18, 2026
Americans Demand Government Intervention Against AI-Driven Job Losses
Mar 18, 2026